関連する実験動画
Updated: Sep 9, 2025

04:20
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
1.0K
FAM49BはPI3K/AKT経路を活性化することで,腫瘍の進行と胃がんの悪い予後を媒介する
Huimin Yang1, Yanxia Ji2, Yingzhe Ju2
1Department of Oncology, Handan Central Hospital, No. 59, Congtaibei Road, Congtai District, Handan City, 056002, Hebei Province, People's Republic of China. yanghuimin1029@21cn.com.
Journal of molecular histology
|September 2, 2025
まとめ
配列相似性49の家族B (FAM49B) は胃がんの成長と免疫回避を促進する. FAM49Bのアップレギュレーションは,PI3K/AKT/mTOR経路によるがん進行におけるその役割を強調し,予後が悪いと相関しています.
科学分野:
- 腫瘍学
- 分子生物学
- 免疫学
背景:
- 胃がんは,世界的に顕著な悪性腫瘍です.
- 胃がんにおけるシーケンスの類似性を持つFAM49B (FAM49B) の役割は,大部分は未定である.
- FAM49Bは様々な悪性腫瘍の発生と拡散に関与しています.
研究 の 目的:
- 胃がんにおけるFAM49Bの発現を調査する.
- 胃がんの進行におけるFAM49Bの機能的役割と背後にあるメカニズムを解明する.
- 胃がん患者のFAM49B発現と臨床病理学的特徴の関係を決定する.
主な方法:
- 胃がん組織におけるFAM49B発現分析
- AGSおよびHGC-27細胞系におけるレンチウイルスベクター (sh-FAM49BおよびFAM49B過剰表現プラズミッド) を使用した機能喪失および機能獲得アッセイ.
- 細胞の生存,増殖 (EDU),侵入,免疫細胞の調節 (CD8+ T細胞,PD-L1,IL-10,IFN-γ) を評価するインビトロ検査.
- 裸のマウスにsh- FAM49Bを発現するAGS細胞を皮下注入したin vivo試験.
- PI3K/AKT/mTOR経路の活性化を評価するウェスタンブロット分析
- 740Y-Pを用いたPI3K/AKT/mTOR経路の薬理学的抑制
主要な成果:
- 胃がんではFAM49Bが著しく上昇し,予後不良と相関していました.
- FAM49Bの過剰発現は,細胞活力,増殖,侵入,PD- L1発現,およびIL-10レベルを向上させ,同時にCD8+T細胞の割合とIFN- γ濃度をインビトロで低下させた.
- FAM49Bのノックダウンにより,腫瘍のサイズ,体重,およびPD- L1/ IFN- γタンパク質のレベルがin vivoで低下した.
- FAM49BはPI3K/ AKT/ mTORシグナル伝達経路の活性化をインビトロとインビボの両方で促進した.
- PI3K/ AKT/ mTOR経路阻害剤740Y- PによるFAM49Bの効果の抑制が確認されました.
結論:
- FAM49Bは胃がんにおける腫瘍遺伝子として作用し,腫瘍の成長と侵入を促進します.
- FAM49Bは,PD- L1とIL- 10を上調し,IFN- γとCD8+T細胞を下調することで,腫瘍の微小環境における免疫脱出に寄与する.
- 胃がんにおけるFAM49Bの腫瘍性機能は,PI3K/ AKT/ mTORシグナル伝達経路の活性化によって媒介される.
- FAM49Bは胃がん治療の潜在的治療標的である.
関連する概念動画
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K

